Mesothelin, a glycosylphosphatidylinositol (GPI)-anchored glycoprotein, is a tumor differentiation antigen frequently expressed at high levels in tumors, such as mesothelioma, ovarian, pancreatic, and lung adenocarcinomas, and showing restricted expression in nonmalignant tissues [31]. Here, MSLN is linked to lung adenocarcinoma.